19937 results for «»
19937 results
Commissural alignment during TAVI
13 Sep 2023
As lifetime management of aortic valve disease patients undergoing TAVI is gaining increased attention, this article sought to summarize the principal idea and possible technical implementation of commissural alignment with current generation transcatheter heart valves (THVs).

Author

Author

Author
First U.S. patients implanted with innovative FIRE1 remote heart failure monitoring system in early feasibility study
11 Jul 2023
PCRonline @ ESC Congress 2023: the interventional cardiology perspective!
07 Aug 2023
What was new and hot in interventional cardiology at #ESCCongress 2023!
Timing of intervention in patients with severe tricuspid regurgitation
30 Aug 2023
Alex Sticchi interviews Julien Dreyfus about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam, which suggests that, in patients with severe TR, a curative intervention should be considered at an early stage of the disease as assessed by...

Author

Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...

Author
Atrial functional tricuspid regurgitation: Importance of atrial fibrillation and right atrial remodeling and prognostic significance
18 Jul 2023
- When tricuspid regurgitation “begets” tricuspid regurgitation -

Reviewer
Evolution and prognostic impact of right ventricular–pulmonary artery coupling after transcatheter aortic valve replacement
19 Jul 2023
The aim of this study was to comprehensively assess the prognostic impact of TAPSE/PASP and its longitudinal variation in AS patients undergoing TAVR.

Reviewer

Reviewer
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation
27 Aug 2023
Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial
Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.
Note the assumptions in this article are based on the presentation...

Author
TEER versus mitral surgery: Data from a nationwide analysis
26 Aug 2023
Alessandro Sticchi interviews Pierre Deharo about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam.
When comparing long-term outcomes of transcatheter edge-to-edge repair (TEER) versus isolated mitral valve repair surgery, the analysis revealed that cardiovascular death was lower among...

Author

Author
P2Y12 inhibitor monotherapy vs DAPT after PCI with BP-EES: The SHARE Randomized Clinical Trial
26 Aug 2023
Elad Asher provides his take on the final results of the SHARE (SHort-term Dual Antiplatelet Therapy After Deployment of BioabsoRbable Polymer Everolimus-Eluting Stent) trial, which were presented during the ESC 2023 congress in Amsterdam by Pil-Ki Min.

Author
FIRE trial: physiology-guided complete PCI in older MI patients
27 Aug 2023
Luis Ortega-Paz interviews Simone Biscaglia and Gianluca Campo about the FIRE trial.
Results showed elderly patients presenting with either STEMI or NSTEMI benefit from complete revascularization, reducing cardiovascular events risk at 1 year compared to culprit lesion-only PCI.
Published simultaneously in the New England Journal of Medicine

Author

Author

Author
ECLS-SHOCK: venoarterial membrane oxygenation in cardiogenic shock
27 Aug 2023
Panos Xaplanteris & Leonidas Koliastasis provide their take on the final results of the ECLS-SHOCK (Extracorporeal Life Support in Infarct-Related Cardiogenic Shock) which were presented by Holger Thiele during the ESC 2023 congress in Amsterdam.

Author

Author
STOPDAPT-3: an aspirin-free antithrombotic strategy for percutaneous coronary intervention
28 Aug 2023
Aaysha Cader interviews Masahiro Natsuaki about the design and results of the STOPDAPT-3 trial which he presented during the ESC Congress 2023 in Amsterdam.
Prasugrel monotherapy after PCI with drug-eluting stents was not superior to dual-antiplatelet therapy (DAPT) for major bleeding but was non-inferior for cardiovascular events...

Author

Author
MULTISTARS AMI: Multivessel immediate versus staged revascularization in STEMI
28 Aug 2023
Aaysha Cader interviews Barbara Elisabeth Stahli on the study design and results that she presented during the ESC Congress 2023 in Amsterdam.
Immediate multivessel PCI was non-inferior to staged multivessel PCI for reducing death and ischemic events in patients with STEMI and multivessel coronary artery disease.

Author

Author
Tatyana Brame
Toulouse, Lebanon
Peter Chang
Singapore, Singapore
Cipto Fidianto
Bandung, Indonesia
Kwee Fong Hoe
Singapore, Singapore
James Howard
London, United Kingdom
Pooi Wan Joyce Lee
Singapore, Singapore